Table 2.

Respondents willingness to prescribe PrEP in certain patient populations (n, %).

I would be willing to prescribe Truvada® for HIV Preexposure Prophylaxis (PrEP) to the following patient population(s) if there are no contraindications (n = 17):
	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Sexually active adult men who have sex with men (MSM) at substantial risk of HIV acquisition.	8 (47%)	5 (29%)	2 (12%)	0 (0%)	2 (12%)
Heterosexually active men and women at substantial risk of HIV acquisition.	8 (47%)	5 (29%)	2 (12%)	0 (0%)	2 (12%)
Heterosexually active men and women whose partners are known to have HIV infections to protect the uninfected partner during conception and pregnancy.	10 (59%)	3 (18%)	3 (18%)	0 (0%)	1 (6%)